In stroke patients, plasma OPG levels are associated with the burden of cerebral atherosclerosis and poor prognosis (Kim et al., 2013; Nezu et al., 2015; Song et al., 2012; Wu et al., 2016). This evidence concerns the gene TNFRSF11B and stroke disorder.